SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001558370-22-005385
Filing Date
2022-04-13
Accepted
2022-04-13 17:07:30
Documents
9
Period of Report
2022-06-15

Document Format Files

Seq Description Document Type Size
1 PRE 14A imgn-20220615xpre14a.htm PRE 14A 1409283
2 GRAPHIC imgn-20220615xpre14a002.jpg GRAPHIC 6096
3 GRAPHIC imgn-20220615xpre14a003.jpg GRAPHIC 5387
4 GRAPHIC imgn-20220615xpre14a025.jpg GRAPHIC 120547
5 GRAPHIC imgn-20220615xpre14a024.jpg GRAPHIC 132650
6 GRAPHIC imgn-20220615xpre14a015.jpg GRAPHIC 29658
7 GRAPHIC imgn-20220615xpre14a001.jpg GRAPHIC 6192
8 GRAPHIC imgn-20220615xpre14a017.jpg GRAPHIC 22926
9 GRAPHIC imgn-20220615xpre14a016.jpg GRAPHIC 43144
  Complete submission text file 0001558370-22-005385.txt   1916488
Mailing Address 830 WINTER ST WALTHAM MA 02451
Business Address 830 WINTER ST WALTHAM MA 02451 (781)895-0600
ImmunoGen, Inc. (Filer) CIK: 0000855654 (see all company filings)

IRS No.: 042726691 | State of Incorp.: MA | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 000-17999 | Film No.: 22825306
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences